- Home
- EDSA vs VERB Comparison
EDSA vs VERB Comparison
Compare EDSA & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- VERB
- Stock Information
- Founded
- EDSA 2015
- VERB 2014
- Country
- EDSA Canada
- VERB United States
- Employees
- EDSA N/A
- VERB N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- VERB Other Consumer Services
- Sector
- EDSA Health Care
- VERB Consumer Discretionary
- Exchange
- EDSA Nasdaq
- VERB Nasdaq
- Market Cap
- EDSA 6.2M
- VERB 5.8M
- IPO Year
- EDSA N/A
- VERB N/A
- Fundamental
- Price
- EDSA $1.83
- VERB $8.98
- Analyst Decision
- EDSA Strong Buy
- VERB Strong Buy
- Analyst Count
- EDSA 1
- VERB 1
- Target Price
- EDSA $21.00
- VERB $62.00
- AVG Volume (30 Days)
- EDSA 35.8K
- VERB 111.1K
- Earning Date
- EDSA 05-14-2025
- VERB 05-13-2025
- Dividend Yield
- EDSA N/A
- VERB N/A
- EPS Growth
- EDSA N/A
- VERB N/A
- EPS
- EDSA N/A
- VERB N/A
- Revenue
- EDSA N/A
- VERB $2,193,000.00
- Revenue This Year
- EDSA N/A
- VERB $287.49
- Revenue Next Year
- EDSA N/A
- VERB $47.06
- P/E Ratio
- EDSA N/A
- VERB N/A
- Revenue Growth
- EDSA N/A
- VERB 3125.00
- 52 Week Low
- EDSA $1.55
- VERB $3.81
- 52 Week High
- EDSA $5.59
- VERB $30.98
- Technical
- Relative Strength Index (RSI)
- EDSA 29.28
- VERB 73.50
- Support Level
- EDSA $1.88
- VERB $5.94
- Resistance Level
- EDSA $2.05
- VERB $8.49
- Average True Range (ATR)
- EDSA 0.08
- VERB 0.67
- MACD
- EDSA -0.00
- VERB 0.23
- Stochastic Oscillator
- EDSA 0.00
- VERB 83.31
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.